ASAH1 and early-onset autosomal dominant Alzheimer disease: ASAH1 catalyzes the conversion of ceramide into sphingosine and fatty acid and has been associated with pathologies such as Farber’s disease, Alzheimer’s disease, cancer, diabetes, and spinal muscular atrophy [25–27].